Illumina has completed its USD 350 million acquisition of SomaLogic, strengthening its multiomics portfolio and expanding large-scale proteomics capabilities to accelerate drug discovery and improve patient outcomes.
SomaLogic | 02/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy